America Clinical Trials, originally founded in 2002 as a department of the Metabolic Institute of America, has developed into a major research institute bearing its own name in 2012. ACT is led by nationally-recognized medical metabolic leader, Yehuda Handelsman, MD as principal investigator and in coordination with other physician leaders serving as investigators for various studies.
Heart in Diabetes (HiD), now in its 4th year, is a unique medical conference bringing together world-renowned clinical leaders in diabetes and cardiovascular disease. The program is designed to evaluate the state-of-the-art clinical data and research, while focusing on the management of the heart and kidney in diabetes. The goal is to align cardiologists, endocrinologists, diabetologists, hepatologists, nephrologists and all other interested clinicians in their understanding and development of appropriate comprehensive clinical management plans for very high-risk patients.
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 18th year, is a unique and exciting multidisciplinary program. The congress is the premiere global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease and energy balance. The program is designed to evaluate the existing clinical and basic science, understand pathophysiology, and develop appropriate comprehensive clinical management plans. The congress' intimate setting promotes a lot of personal contact between participants and the faculty wherein everyone learns from the free flow of questions and personal observations.